Ricercatrice UNISA Baronissi
📍 Università degli Studi di Salerno — Dipartimento di Medicina, Chirurgia ed Odontoiatria
Bourse reçue: €3.000Sviluppo di un test non invasivo basato su biomarcatori salivari (genetici, microbioma, immunologici) per predire chi tra i pazienti con tumore al polmone svilupperà reazioni avverse immuno-correlate (IRAEs) prima dell'inizio della terapia. Approccio precision medicine + medicina di laboratorio accessibile.
To advance precision oncology by implementing Immuno-SAFE, a rapid and non-invasive system predicting severe irAEs in NSCLC patients eligible for anti-PD-1/PD-L1 immunotherapy. The project aims to improve treatment personalization, enhance patient safety, reduce avoidable hospitalizations, and support the regional and national transition toward more efficient, sustainable immunotherapy management.
Early and accurate identification of NSCLC patients at high risk of severe irAEs, enabling more personalized and safer immunotherapy pathways. Reduction of treatment interruptions, emergency admissions, and irAE-related healthcare costs. Strengthened precision oncology services across regional cente…
Chaque 3 000 € collectés = un grant de plus pour le prochain appel. Vous courez, vous donnez, ils font de la recherche.
Faire un don Voir l'appel ouvert